Workflow
After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?
GLPGlobal Partners LP(GLP) The Motley Fool·2024-12-03 13:27

There's a growing number of companies entering the weight loss space, focusing on GLP-1 drugs which can be game changers for their businesses. And one of them is Viking Therapeutics (VKTX -2.70%), which has a promising GLP-1 treatment in development that investors are hopeful will generate billions in revenue for the modestly sized healthcare company. It may even lead to an acquisition.In the past month, however, excitement around Viking has cooled, considerably. During November, the stock fell by 27%, hitt ...